University of Notre Dame du Lac’s Atara Biotherapeutics ATRA Stock Holding History

University of Notre Dame du Lac’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,969	Closed	-$10.9M	–	58
2019 Q1	$10.9M	Sell	10,969 -149	-1%	-$138K	2.43%	8
2018 Q4	$9.66M	Buy	11,118 +8,230	+285%	+$7.64M	2.34%	8
2018 Q3	$2.98M	Sell	2,888 -7,109	-71%	-$6.95M	0.55%	51
2018 Q2	$9.19M	Buy	9,997 +7,871	+370%	+$8.46M	1.78%	17
2018 Q1	$2.07M	Buy	+2,126	New	+$1.94M	0.39%	72

Other funds holding ATRA

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

University of Notre Dame du Lac's ATRA Position: Q2 2019 in Review

University of Notre Dame du Lac sold out of Atara Biotherapeutics (ATRA) in Q2 2019, closing a stake of 10,969 shares — an estimated $10.9M sold.

University of Notre Dame du Lac first reported a position in ATRA in Q1 2018 and held it in 5 quarters. The position peaked at $10.9M in Q1 2019. 116 funds tracked by Wall St. Rank hold ATRA as of Q2 2019.

University of Notre Dame du Lac reported no remaining Atara Biotherapeutics position as of Q2 2019 after selling out during the quarter.
University of Notre Dame du Lac sold 10,969 Atara Biotherapeutics shares in Q2 2019, an estimated $10.9M.
University of Notre Dame du Lac first reported a position in Atara Biotherapeutics in Q1 2018 and held it in 5 quarters.
University of Notre Dame du Lac's Atara Biotherapeutics position peaked at $10.9M in Q1 2019.
116 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2019.

Based on University of Notre Dame du Lac's 13F filing for Q2 2019, filed 14 Aug 2019.